In the 2017 WHO lymphoma classification, MYC/BCL6-DH DLBCL are included in the double-hit category, without any distinction from those with MYC/BCL2/BCL6-TH or MYC/BCL2-DH [55]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.